What does CUSIP 405024100 represent in this 13F holders report?

CUSIP 405024100 is the security identifier for HAE - HAEMONETICS CORP - Common stock, $.01 par value per share used to aggregate holder disclosures.

How many institutions held HAE - HAEMONETICS CORP - Common stock, $.01 par value per share in Q1 2018?

254 institutional investors reported HAE - HAEMONETICS CORP - Common stock, $.01 par value per share for Q1 2018. Use the holders table for investor-level position and value details.

HAEMONETICS CORP - Common stock, $.01 par value per share (HAE)

CUSIP: 405024100

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class: Equity / Common stock, $.01 par value per share
Shares outstanding: 46,498,422
Total 13F shares: 52,583,034
Share change: -85,450
Total reported value: $3,847,182,644
Put/Call ratio: 0%
Price per share: $73.16
Number of holders: 254
Value change: +$17,637,230
Number of buys: 122
Number of sells: 125

Quarterly Holders Quick Answers

What is CUSIP 405024100?
CUSIP 405024100 identifies HAE - HAEMONETICS CORP - Common stock, $.01 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2018
Previous quarter: Q4 2017

Recent filing periods for CUSIP 405024100:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of HAE - HAEMONETICS CORP - Common stock, $.01 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	14%	6,670,988	$387,452,000	—	31 Dec 2017	13F
VANGUARD GROUP INC	13F	Company	11%	5,016,695	$291,370,000	—	31 Dec 2017	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	8.2%	3,792,684	$220,279,000	—	31 Dec 2017	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	5.2%	2,428,236	$141,032,000	—	31 Dec 2017	13F
WELLS FARGO & COMPANY/MN	13F	Company	4.6%	2,117,705	$122,996,000	—	31 Dec 2017	13F
Neuberger Berman Group LLC	13F	Company	4.2%	1,945,422	$113,061,000	—	31 Dec 2017	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	3.4%	1,601,253	$93,002,000	—	31 Dec 2017	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	3.3%	1,524,222	$88,527,000	—	31 Dec 2017	13F
HealthCor Management, L.P.	13F	Company	3.1%	1,450,000	$84,216,000	—	31 Dec 2017	13F
STATE STREET CORP	13F	Company	3%	1,397,511	$81,165,000	—	31 Dec 2017	13F
FRANKLIN RESOURCES INC	13F	Company	2.2%	1,000,000	$58,080,000	—	31 Dec 2017	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	2.1%	977,100	$56,750,000	—	31 Dec 2017	13F
Van Berkom & Associates Inc.	13F	Company	2.1%	973,593	$56,546,000	—	31 Dec 2017	13F
Nitorum Capital, L.P.	13F	Company	2.1%	962,827	$55,921,000	—	31 Dec 2017	13F
NORGES BANK	13F	Company	2.1%	953,373	$55,372,000	—	31 Dec 2017	13F
COLUMBIA WANGER ASSET MANAGEMENT LLC	13F	Company	2%	907,049	$52,681,000	—	31 Dec 2017	13F
AJO, LP	13F	Company	1.9%	883,494	$51,313,000	—	31 Dec 2017	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	1.7%	784,893	$45,587,000	—	31 Dec 2017	13F
FULLER & THALER ASSET MANAGEMENT, INC.	13F	Company	1.6%	751,080	$43,623,000	—	31 Dec 2017	13F
ANCHOR CAPITAL ADVISORS LLC	13F	Company	1.6%	744,564	$43,244,000	—	31 Dec 2017	13F
ROYAL BANK OF CANADA	13F	Company	1.6%	737,428	$42,831,000	—	31 Dec 2017	13F
MACQUARIE GROUP LTD	13F	Company	1.5%	677,150	$39,329,000	—	31 Dec 2017	13F
NORTHERN TRUST CORP	13F	Company	1.5%	676,699	$39,302,000	—	31 Dec 2017	13F
Bank of New York Mellon Corp	13F	Company	1.4%	664,964	$38,622,000	—	31 Dec 2017	13F
AMERIPRISE FINANCIAL INC	13F	Company	1.2%	555,329	$32,257,000	—	31 Dec 2017	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	1.2%	554,652	$32,215,000	—	31 Dec 2017	13F
BANK OF AMERICA CORP /DE/	13F	Company	1.1%	532,849	$30,949,000	—	31 Dec 2017	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	1.1%	524,768	$30,479,000	—	31 Dec 2017	13F
Point72 Asset Management, L.P.	13F	Company	1%	477,200	$27,716,000	—	31 Dec 2017	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1%	476,203	$27,657,000	—	31 Dec 2017	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.93%	430,375	$24,997,000	—	31 Dec 2017	13F
AMERICAN CAPITAL MANAGEMENT INC	13F	Company	0.91%	421,296	$24,469,000	—	31 Dec 2017	13F
Invesco Ltd.	13F	Company	0.78%	361,769	$21,012,000	—	31 Dec 2017	13F
Capital Research Global Investors	13F	Company	0.76%	353,459	$20,529,000	—	31 Dec 2017	13F
CHARTWELL INVESTMENT PARTNERS, LLC	13F	Company	0.7%	325,118	$18,883,000	—	31 Dec 2017	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.67%	313,305	$18,197,000	—	31 Dec 2017	13F
DEUTSCHE BANK AG\	13F	Company	0.65%	300,625	$17,458,000	—	31 Dec 2017	13F
Boston Trust Walden Corp	13F	Company	0.62%	287,036	$16,671,000	—	31 Dec 2017	13F
FORT WASHINGTON INVESTMENT ADVISORS INC /OH/	13F	Company	0.61%	284,138	$16,503,000	—	31 Dec 2017	13F
Marshall Wace North America L.P.	13F	Company	0.6%	279,811	$16,251,000	—	31 Dec 2017	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.58%	270,197	$15,693,000	—	31 Dec 2017	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.52%	244,023	$14,173,000	—	31 Dec 2017	13F
Fisher Asset Management, LLC	13F	Company	0.49%	225,639	$13,105,000	—	31 Dec 2017	13F
CHILTON INVESTMENT CO INC.	13F	Company	0.47%	217,825	$12,651,000	—	31 Dec 2017	13F
BOGLE INVESTMENT MANAGEMENT L P /DE/	13F	Company	0.46%	215,757	$12,531,000	—	31 Dec 2017	13F
MORGAN STANLEY	13F	Company	0.42%	196,854	$11,434,000	—	31 Dec 2017	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.42%	193,013	$11,210,000	—	31 Dec 2017	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.4%	186,840	$10,852,000	—	31 Dec 2017	13F
SEGALL BRYANT & HAMILL, LLC	13F	Company	0.4%	186,114	$10,810,000	—	31 Dec 2017	13F
CASTLEARK MANAGEMENT LLC	13F	Company	0.39%	181,495	$10,541,000	—	31 Dec 2017	13F

Institutional Holders of HAEMONETICS CORP - Common stock, $.01 par value per share (HAE) as of Q1 2018

As of 31 Mar 2018, HAEMONETICS CORP - Common stock, $.01 par value per share (HAE) was held by 254 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 52,583,034 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, WELLS FARGO & COMPANY/MN, Neuberger Berman Group LLC, DIMENSIONAL FUND ADVISORS LP, VICTORY CAPITAL MANAGEMENT INC, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, and AMERIPRISE FINANCIAL INC. This page lists 254 institutional shareholders reporting positions in this security for the Q1 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2018 vs Q4 2017 Across Filers

Q4 2017 holders

240

Q1 2018 holders

254

Holder diff

Investor	Q4 2017 Shares	Q1 2018 Shares	Share Diff	Share Chg %	Q4 2017 Value $	Q1 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.